Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL717623

CCCC[N+]1(C)CCCCCC1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 2/20 0.40
LMNA P02545 3/20 0.36
APOBEC3A P31941 2/20 0.36
APOBEC3G Q9HC16 2/20 0.36
KMT2A Q03164 1/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
BLM P54132 1/20 0.36
PMP22 Q01453 1/20 0.36
KCNH2 Q12809 7/20 0.36
KDM4E B2RXH2 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
ACHE P22303 3/20 0.32
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL318063 1.00 BBOX1 (0.40) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A
Trifluoromethanesulfonic Acid SCHEMBL30697434 0.98 BBOX1 (0.41) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A
Trifluoromethanesulfonic Acid SCHEMBL246591 0.98 BBOX1 (0.41) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A
Trifluoromethanesulfonic Acid SCHEMBL29252614 0.94 LMNA (0.41) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A
Trifluoromethanesulfonic Acid SCHEMBL29252752 0.94 LMNA (0.41) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A
Trifluoromethanesulfonic Acid SCHEMBL4166764 0.94 LMNA (0.41) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A
Trifluoromethanesulfonic Acid SCHEMBL29252359 0.94 LMNA (0.41) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A
Trifluoromethanesulfonic Acid SCHEMBL29252078 0.94 LMNA (0.41) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A
Trifluoromethanesulfonic Acid SCHEMBL30330764 0.94 LMNA (0.41) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A
Trifluoromethanesulfonic Acid SCHEMBL30331399 0.93 LMNA (0.40) BBOX1LMNAAPOBEC3AAPOBEC3GKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090284-A1 ELECTROLYTE COMPRISING SOLVENT WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-05-01 WO claimed
WO-2025049222-A1 ELECTROLYTE COMPRISING CYCLIC QUATERNARY AMMONIUM IONIC LIQUID AND SOLVENT WITH HIGH BOILING POINT AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-03-06 WO claimed
US-20250309354-A1 ELECTROLYTE COMPRISING AROMATIC COMPOUND WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME FACTORIAL INC. 2025-10-02 US disclosed
WO-2025090284-A1 ELECTROLYTE COMPRISING SOLVENT WITH NON-FLUORINE HALOGEN SUBSTITUTE AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-05-01 WO disclosed
WO-2025049222-A1 ELECTROLYTE COMPRISING CYCLIC QUATERNARY AMMONIUM IONIC LIQUID AND SOLVENT WITH HIGH BOILING POINT AND BATTERIES COMPRISING SAME FACTORIAL INC. (US) 2025-03-06 WO disclosed
US-8345407-B2 Low viscosity ionic liquids INVISTA NORTH AMERICA S.A R.L. (US) 2013-01-01 US disclosed
EP-2534134-A1 LOW VISCOSITY IONIC LIQUIDS Invista Technologies S.à.r.l. (CH) 2012-12-19 EP disclosed
US-20120050945-A1 LOW VISCOSITY IONIC LIQUIDS INVISTA NORTH AMERICA S.A R.L. (US) 2012-03-01 US disclosed
WO-2011100232-A1 LOW VISCOSITY IONIC LIQUIDS INVISTA TECHNOLOGIES S.A R.L. (CH) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120050945-A1 LOW VISCOSITY IONIC LIQUIDS H1-3, H1-0, H1-2 BBOX1 4324/4885LMNA 678/4885APOBEC3A 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.